Literature DB >> 27349407

Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies.

Ana M Cárdenas1, Arlek M González-Jamett2, Luis A Cea3, Jorge A Bevilacqua3, Pablo Caviedes4.   

Abstract

Mutations in the dysferlin gene are linked to a group of muscular dystrophies known as dysferlinopathies. These myopathies are characterized by progressive atrophy. Studies in muscle tissue from dysferlinopathy patients or dysferlin-deficient mice point out its importance in membrane repair. However, expression of dysferlin homologous proteins that restore sarcolemma repair function in dysferlinopathy animal models fail to arrest muscle wasting, therefore suggesting that dysferlin plays other critical roles in muscle function. In the present review, we discuss dysferlin functions in the skeletal muscle, as well as pathological mechanisms related to dysferlin mutations. Particular focus is presented related the effect of dysferlin on cell membrane related function, which affect its repair, vesicle trafficking, as well as Ca(2+) homeostasis. Such mechanisms could provide accessible targets for pharmacological therapies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Connexin hemichannels; Dysferlin; Dysferlinopathies; Inflammatory processes; Membrane repair; Muscular dystrophies; Vesicle trafficking

Mesh:

Substances:

Year:  2016        PMID: 27349407     DOI: 10.1016/j.expneurol.2016.06.026

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  22 in total

1.  Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.

Authors:  Liubov V Gushchina; Sayak Bhattacharya; Kevin E McElhanon; Jin Hyuk Choi; Heather Manring; Eric X Beck; Jenna Alloush; Noah Weisleder
Journal:  Mol Ther       Date:  2017-07-03       Impact factor: 11.454

2.  Improved efficacy of a next-generation ERT in murine Pompe disease.

Authors:  Su Xu; Yi Lun; Michelle Frascella; Anadina Garcia; Rebecca Soska; Anju Nair; Abdul S Ponery; Adriane Schilling; Jessie Feng; Steven Tuske; Maria Cecilia Della Valle; José A Martina; Evelyn Ralston; Russell Gotschall; Kenneth J Valenzano; Rosa Puertollano; Hung V Do; Nina Raben; Richie Khanna
Journal:  JCI Insight       Date:  2019-03-07

Review 3.  The regulatory role of Myomaker and Myomixer-Myomerger-Minion in muscle development and regeneration.

Authors:  Bide Chen; Wenjing You; Yizhen Wang; Tizhong Shan
Journal:  Cell Mol Life Sci       Date:  2019-10-23       Impact factor: 9.261

4.  CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Progressive Muscular Dystrophy: A Case Report.

Authors:  Liting Chen; Bin Xu; Wanying Liu; Di Wang; Jinhuan Xu; Xia Mao; Min Xiao; Jianfeng Zhou; Yi Xiao
Journal:  Onco Targets Ther       Date:  2022-04-08       Impact factor: 4.147

5.  Serum exosomes can restore cellular function in vitro and be used for diagnosis in dysferlinopathy.

Authors:  Xue Dong; Xianjun Gao; Yi Dai; Ning Ran; HaiFang Yin
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

6.  N-Acetylcysteine Reduces Skeletal Muscles Oxidative Stress and Improves Grip Strength in Dysferlin-Deficient Bla/J Mice.

Authors:  Paz García-Campos; Ximena Báez-Matus; Carlos Jara-Gutiérrez; Marilyn Paz-Araos; César Astorga; Luis A Cea; Viviana Rodríguez; Jorge A Bevilacqua; Pablo Caviedes; Ana M Cárdenas
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

7.  Formation of Aberrant Myotubes by Myoblasts Lacking Myosin VI Is Associated with Alterations in the Cytoskeleton Organization, Myoblast Adhesion and Fusion.

Authors:  Lilya Lehka; Małgorzata Topolewska; Dominika Wojton; Olena Karatsai; Paloma Alvarez-Suarez; Paweł Pomorski; Maria Jolanta Rędowicz
Journal:  Cells       Date:  2020-07-11       Impact factor: 6.600

8.  Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice.

Authors:  Erin M Lloyd; Hongyang Xu; Robyn M Murphy; Miranda D Grounds; Gavin J Pinniger
Journal:  PLoS One       Date:  2019-04-10       Impact factor: 3.240

Review 9.  Myoblast fusion confusion: the resolution begins.

Authors:  Srihari C Sampath; Srinath C Sampath; Douglas P Millay
Journal:  Skelet Muscle       Date:  2018-01-31       Impact factor: 4.912

Review 10.  Into the breach: how cells cope with wounds.

Authors:  Mitsutoshi Nakamura; Andrew N M Dominguez; Jacob R Decker; Alexander J Hull; Jeffrey M Verboon; Susan M Parkhurst
Journal:  Open Biol       Date:  2018-10-03       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.